Astma
Topics: Asthma, Disease Management
|
Chronic Obstructive Pulmonary Disease (COPD)
Topics: Asthma, Disease Management, General Insurance & Managed Care, Respiratory/Pulmonary
|
2012 Pharmaceuticals Research Review
Topics: Asthma, Pharmaceuticals, Manufacturing, Packaging & Detailing, Research & Development, Drug Discovery, CNS/Neurology
|
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H2, 2012
Topics: Asthma, Clinical Trial, Respiratory/Pulmonary
Regions: Global
|
Epidemiology: COPD in China – Aging, population growth, and increased survival will drive up prevalent cases over the next decade
Topics: Asthma, Research & Development, Gerontology/Aging, Respiratory/Pulmonary
Regions: China
|
Asthma – Pipeline Review, H2 2012
Topics: Asthma, Drug Discovery
|
Market and Product Forecasts: Asthma – Premium products to offset loss to generics
Topics: Asthma, Generics Drugs, Manufacturing, Packaging & Detailing, Prescription Drugs
|
China Asthmatic Prescription Drugs Sales Data 2006-2011
Topics: Asthma, Prescription Drugs
Regions: China
|
Chinese Markets for Asthma Treatment Drugs
Topics: Asthma, Manufacturing, Packaging & Detailing, Research & Development, Prescription Drugs, Drug Discovery
Regions: China
|
Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2012
Topics: Asthma, Drug Discovery, Respiratory/Pulmonary
|
Epidemiology: COPD – Aging population and stable smoking rates to raise case numbers
Topics: Asthma, Gerontology/Aging, Smoking Cessation
|
Global Markets for Asthma and COPD Drugs
Topics: Asthma, Research & Development, Prescription Drugs, Drug Discovery, Respiratory/Pulmonary
Regions: Global
|
Epidemiology: Asthma – Stable prevalence rates in all age groups will lead to stable case numbers
Topics: Asthma
|
Asthma Global Clinical Trials Review, H1, 2012
Topics: Asthma, Drug Discovery, Clinical Trial
Regions: Global
|
Inhalation & Nasal Spray Generic Drugs 2012
Topics: Asthma, Respiratory Devices, Generics Drugs, Respiratory/Pulmonary
|
Product Profiles: Asthma – Key companies act to maintain dominance
Topics: Asthma, Generics Drugs, Research & Development, Drug Discovery
|
Product Profiles: COPD – Novel combinations race to the finish
Topics: Asthma, Drug Discovery, Respiratory/Pulmonary
|
Asthma – Executive Market Summary 2011
Topics: Asthma, Drug Discovery
|
Chronic Obstructive Pulmonary Disease (COPD) – Executive Market Summary 2011
Topics: Asthma, Drug Discovery, Respiratory/Pulmonary
|
R&D Trends: Asthma – Extensive investment in novel targets
Topics: Asthma, Research & Development, Drug Discovery, Clinical Trial
|
Conference Documentation: Asthma & COPD
Topics: Asthma, Respiratory/Pulmonary
|
R&D Trends: COPD – Simplified therapies are gaining traction
Topics: Asthma, Research & Development, Drug Discovery, Clinical Trial, Respiratory/Pulmonary
|
Chronic Obstructive Pulmonary Disease
Topics: Asthma, Drug Discovery, Respiratory/Pulmonary
|
Asthma – Pipeline Review, H1 2012
Topics: Asthma, Drug Discovery
|
Asthma Global Clinical Trials Review, H2, 2011
Topics: Asthma, Clinical Trial
Regions: Global
|
COPD in China Forecast
Topics: Asthma, Drug Discovery, Respiratory/Pulmonary
Regions: China
|
COPD Market Forecast
Topics: Asthma
|
Clinical Trial Recruitment in Respiratory Diseases - Most Clinical Trial Activity Focused on Asthma and COPD
Topics: Asthma, Clinical Trial, Respiratory/Pulmonary
|
Telemonitoring: Challenges & Opportunities
Topics: Asthma, Telemedicine, Patient Monitoring
Regions: United States
|
Product Profiles: COPD in China – Novel therapies to diversify treatment options
Topics: Asthma, Research & Development, Drug Discovery, Respiratory/Pulmonary
Regions: China
|
Industry Outlook: Trends in Respiratory Disease Strategies
Topics: Asthma, Respiratory/Pulmonary
|
China Asthmatic Prescription Drugs Sales Data 2006-2010
Topics: Asthma, Prescription Drugs, Respiratory/Pulmonary
Regions: China
|
Product Profiles: Asthma/COPD - Novel combinations edge closer to market
Topics: Asthma, Manufacturing, Packaging & Detailing, Research & Development, Clinical Trial, Respiratory/Pulmonary
|
Conference Documentation: COPD: Novel Therapeutics and Management Strategies
Topics: Management, Asthma, Research & Development, Drug Discovery, Respiratory/Pulmonary
|
Special Report: The Pricing and Reimbursement Environment for Respiratory Disease Therapies
Topics: Asthma, Pricing, Respiratory/Pulmonary
|
Asthma - Pipeline Review, H2 2011
Topics: Asthma, Drug Discovery
|
Epidemiology: Asthma
Topics: Asthma, Drug Discovery, Respiratory/Pulmonary
|
Epidemiology: Asthma
Topics: Asthma
|
Novel Drug Targets and Strategies for Asthma and Chronic Obstructive Pulmonary Disease
Topics: Asthma, Research & Development, Drug Discovery
|
Respiratory Disorders Therapeutics Market to 2017 - Novel Pipeline Molecules such as VX-770 and pirfenidone May Offset Negative Effect of Patent Expiries
Topics: Asthma, Research & Development, Respiratory/Pulmonary
|
Special Report: The Respiratory Disease Pipeline—A Competitive Review
Topics: Asthma, CNS/Neurology
|
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Topics: Asthma, Respiratory/Pulmonary
|
Asthma Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Topics: Asthma
|
Epidemiology: COPD - Aging population and stable smoking rates to raise case numbers
Topics: Asthma, Research & Development, Gerontology/Aging, Respiratory/Pulmonary
Regions: United States
|
Epidemiology: COPD – Aging population and stable smoking rates to raise case numbers
Topics: Asthma, Gerontology/Aging, Smoking Cessation
|
Asthma and COPD Therapies: World Market 2011-2021
Topics: Asthma
Regions: Global
|
Acute Respiratory Distress Syndrome (ARDS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: Asthma, Respiratory/Pulmonary
|
Asthma - Executive Market Summary 2011
Topics: Asthma
|
Chronic Obstructive Pulmonary Disease (COPD) - Executive Market Summary 2011
Topics: Asthma, Respiratory/Pulmonary
|
The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016
Topics: Asthma
|
